Virtus Investment Advisers, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 316 filers reported holding HAEMONETICS CORP in Q2 2024. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus Investment Advisers, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$1,130,257
-3.1%
13,6620.0%0.96%
+14.6%
Q1 2024$1,166,052
-0.2%
13,6620.0%0.83%
-4.7%
Q4 2023$1,168,238
-4.5%
13,6620.0%0.88%
+5.0%
Q3 2023$1,223,842
+5.2%
13,6620.0%0.83%
+5.4%
Q2 2023$1,163,183
+2.9%
13,6620.0%0.79%
-0.3%
Q1 2023$1,130,531
+143.0%
13,662
+130.9%
0.79%
+155.5%
Q4 2022$465,293
+6.2%
5,9160.0%0.31%
+54.2%
Q3 2022$438,0005,9160.20%
Other shareholders
HAEMONETICS CORP shareholders Q2 2024
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders